In healthcare settings around the world, people often experience extended delays for accurate diagnostic results. When every minute lost can greatly impact the delivery of care, answers can't wait.
Rapid turnaround of test results is vital to decision-making across a range of care settings, allowing clinicians to gain greater control in evaluating and responding to a patient’s ever-changing condition.
At the link below, read more about how point-of-care testing is used.
Abbott develops and manufactures the i-STAT® System, an advanced, portable blood analyzer that performs a broad range of commonly ordered blood tests to assist in diagnosing and treating a variety of medical conditions. Read more at the link below.
Abbott Point of Care markets a range of products to aid healthcare professionals in delivering the highest quality of care. Click on the links below to learn more about our offerings.
Click on the items of interest below that relate to the field of point-of-care testing.
This presentation will address the updates for Myocardial Infarction Guidelines, discuss the methods for treating Myocardial Infarction (MI), and include a brief over-view of the high-sensitive Troponin and discussion on Troponin Turn-Around-Time (TAT), testing methodologies and a review of quality practices to optimize patient care.REGISTER FEB 21
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The page you are trying to access is best viewed on a desktop or laptop computer.